Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of choice.
However, their use in the treatment of acute venous thromboembolism (VTE) in morbidly …

… Among most patients with AF with an indication for anticoagulation, direct oral
anticoagulants (DOACs), in general, are recommended over warfarin for stroke prevention. …

… ☑ This study evaluated the comparative effectiveness and safety of dabigatran and other
DOACs vs. warfarin in routine care based on a 5-year population-based prospective monitoring …

… first investigation of the comparative effectiveness of the DOACs versus warfarin among NH
residents … with lower rates of adverse outcomes including mortality compared with warfarin. …

… We aimed to examine the comparative effectiveness of VKAs, DTI and FXaI initiating … AF
with an indication for oral anticoagulation included in The Global Anticoagulant Registry in the …

… compared to warfarin [3]. In our study, DOACs and warfarin had similar comparative efficacy
in … there was no difference between the four anticoagulation agents in stroke rates. However, …

… doses of DOAC and warfarin for defining drug exposure. Based on the first oral anticoagulant
prescription, we considered patients exposed to DOAC or to warfarin. In the primary …

… The aim of this study was to determine the comparative effectiveness and safety of direct
oral anticoagulants (DOACs) and warfarin in adults with atrial fibrillation (AF) by level of kidney …

… 273 patients who initiated anticoagulation with warfarin. The pooled HR for … comparing
DOACs to warfarin was 1.02 (95% confidence interval [CI] 0.87 to 1.19). Direct oral anticoagulants …

… Obese patients are underrepresented in clinical trials assessing the comparative effectiveness
and safety of use of direct oral anticoagulants vs use in atrial fibrillation (AF) patients. …